About Optobionics
Optobionics is a company based in Glen Ellyn (United States) founded in 1990. Optobionics has raised $25.15 million across 3 funding rounds from investors including Medtronic, Arch Venture Partners and Advanced Technology Ventures. Optobionics offers products and services including Artificial Silicon Retina (ASR) implants. Optobionics operates in a competitive market with competitors including Kodiak Sciences, Second Sight, Pixium Vision, iScience Interventional and Medical Instrument Development Laboratories, among others.
- Headquarter Glen Ellyn, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Optobionics Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25.15 M (USD)
in 3 rounds
-
Latest Funding Round
$20 M (USD), Series B
Dec 01, 2001
-
Investors
Medtronic
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Optobionics
Optobionics offers a comprehensive portfolio of products and services, including Artificial Silicon Retina (ASR) implants.
Implants designed to stimulate retina for treating Retinitis Pigmentosa vision loss.
Funding Insights of Optobionics
Optobionics has successfully raised a total of $25.15M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in December 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Optobionics
Optobionics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, Arch Venture Partners and Advanced Technology Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm making investment in early stage startups in the US
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked | |
|
US focused venture capital firm
|
Locked | Locked | Locked |
Investor details for Optobionics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Optobionics
Investment portfolio details for Optobionics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Optobionics
Detailed financials for Optobionics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Optobionics Comparisons
Peer comparison for Optobionics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Optobionics
Optobionics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kodiak Sciences, Second Sight, Pixium Vision, iScience Interventional and Medical Instrument Development Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for retinal diseases are developed by the company.
|
|
| Locked | Locked | Locked |
Implantable visual prosthetics for blind individuals are developed and provided.
|
|
| Locked | Locked | Locked |
Bionic vision restoration systems are provided for sight restoration.
|
|
| Locked | Locked | Locked |
Microcatheter and imaging technologies for ophthalmic procedures are developed.
|
|
| Locked | Locked | Locked |
Develops ophthalmic products for ophthalmic system manufacturers
|
|
| Locked | Locked | Locked |
Delivers tailored solutions for treating age-related macular degeneration.
|
Detailed competitors of Optobionics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Optobionics
Complete news archive for Optobionics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optobionics
Optobionics was founded in 1990 and raised its 1st funding round 7 years after it was founded.
Optobionics is headquartered in Glen Ellyn, United States. It is registered at Glen Ellyn, Illinois, United States.
Optobionics is a funded company, having raised a total of $25.15M across 3 funding rounds to date.
Optobionics was founded in 1990 in Glen Ellyn, United States, within the medical device sector focused on retinal implants. An Artificial Silicon Retina microchip, measuring 2 mm in diameter and 25 microns thick with about 5,000 microscopic solar cells, was developed to stimulate damaged retinal cells internally. Visual signals are recreated by these cells and sent to the brain. Operations appear to have ceased, rendering the company non-operational.
Optobionics's top competitors include Kodiak Sciences, Second Sight and Pixium Vision.
Optobionics offers Artificial Silicon Retina (ASR) implants.
Optobionics has 5 investors. Key investors include Medtronic, Arch Venture Partners, Advanced Technology Ventures, Polaris Partners, and Alcon.